October 13, 2016 / 10:31 AM / in a year

BRIEF-Motif Bio sees IPO of 42.5 million ordinary shares

Oct 13 (Reuters) - Motif Bio Plc

* Motif Bio Plc sees IPO of 42.5 million ordinary shares including in form of American depositary shares - SEC filing

* Motif Bio intends to use about $20.5 million of IPO proceeds to fund expenses to be incurred in conducting two Phase 3 clinical trials of Iclaprim Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below